1007308-74-8 Usage
Uses
Used in Pharmaceutical Industry:
7-fluoro-6-nitroquinazoline-2,4(1H,3H)-dione is used as a building block for the synthesis of various pharmaceutical drugs due to its unique structure and reactivity. Its presence in the molecular framework can influence the pharmacological properties of the resulting compounds, making it a valuable component in drug discovery and development processes.
Used in Organic Chemistry Research:
In the field of organic chemistry, 7-fluoro-6-nitroquinazoline-2,4(1H,3H)-dione is utilized as a starting material or intermediate in the synthesis of complex organic compounds. Its distinct functional groups and substituents allow for a wide range of chemical reactions, facilitating the creation of novel molecules with potential applications in various industries.
Used in Medicinal Chemistry:
7-fluoro-6-nitroquinazoline-2,4(1H,3H)-dione is employed as a key component in the design and synthesis of new medicinal agents. Its incorporation into drug candidates can enhance their therapeutic efficacy, selectivity, and pharmacokinetic properties, contributing to the advancement of innovative treatments for various diseases and conditions.
Note: The specific applications and industries for 7-fluoro-6-nitroquinazoline-2,4(1H,3H)-dione may vary based on the context and research findings. The uses listed above are general and may be expanded upon with more detailed information from the materials provided or additional research.
Check Digit Verification of cas no
The CAS Registry Mumber 1007308-74-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,3,0 and 8 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1007308-74:
(9*1)+(8*0)+(7*0)+(6*7)+(5*3)+(4*0)+(3*8)+(2*7)+(1*4)=108
108 % 10 = 8
So 1007308-74-8 is a valid CAS Registry Number.
1007308-74-8Relevant academic research and scientific papers
QUINAZOLINE DERIVATIVE AS PHOSPHODIESTERASE INHIBITOR AND A PROCESS FOR PREPARING THE SAME
-
Page/Page column 26; 70, (2010/11/30)
The present invention relates to a quinazoline derivative, a preparation method thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, a hydrate thereof, a pharmaceutical composition comprising the same and use thereof as a therapeutic agent. The present inveniont relates to a quinazoline derivative exhibiting inhibitory activity against C
